Bank of Montreal
XERS icon

Bank of Montreal’s Xeris Biopharma Holdings XERS Stock Holding History

Bank of Montreal’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,200
Closed -$86.7K – 4239
2022
Q4 		$86.7K Hold
65,200
– – ﹤0.01% 3399
2022
Q3 		$105 Hold
65,200
– – ﹤0.01% 3452
2022
Q2 		$112 Buy
+65,200
New +$138K ﹤0.01% 3430
2021
Q2 		– Sell
-680,700
Closed -$2.9M – 4973
2021
Q1 		$2.9M Sell
680,700
-105,500
-13% -$569K ﹤0.01% 1604
2020
Q4 		$4.51M Buy
786,200
+43,800
+6% +$219K ﹤0.01% 1447
2020
Q3 		$4.3M Buy
+742,400
New +$2.97M ﹤0.01% 1290

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Bank of Montreal's XERS Position: Q3 2022 in Review

Bank of Montreal sold out of Xeris Biopharma Holdings (XERS) in Q3 2022, closing a stake of 103 shares — an estimated $170 sold.

Bank of Montreal first reported a position in XERS in Q3 2018 and held it in 10 quarters. The position peaked at $789K in Q4 2020. 101 funds tracked by Wall St. Rank hold XERS as of Q3 2022.

  • Bank of Montreal reported no remaining Xeris Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 103 Xeris Biopharma Holdings shares in Q3 2022, an estimated $170.
  • Bank of Montreal first reported a position in Xeris Biopharma Holdings in Q3 2018 and held it in 10 quarters.
  • Bank of Montreal's Xeris Biopharma Holdings position peaked at $789K in Q4 2020.
  • 101 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.